Toshiro Sakaki graduated from the University of Tokyo in 1984 and holds a Ph.D. in Pharmaceutical Sciences.
Since joining Tanabe Pharma in 1986, he has been extensively involved in pharmaceutical research and development, marketing, and business development, leading and managing a wide range of strategic projects.
From 2015, he focused on exploring new business opportunities and driving innovation in healthcare through the Future Design and Digital Transformation divisions, with a particular emphasis on shaping the future of medicine and healthcare.
In 2020, he founded SAT Research Institute, a consulting firm specializing in the pharmaceutical and healthcare industries.
He currently serves as Vice Chair of the Healthcare Research Committee of the Japan Bioindustry Association (JBA).
